Individualisation of hormone replacement therapy

Tuimala RJ , Vihtamaki T , Individual hormone replacement therapy, Maturitas 1996; Suppl: S87-90.

Michaelsson K , Baron JA , Farahmand BY Hormone replacement therapy and risk of hip fracture: Population based case-control study. The Swedish Hip Fracture Study Group. BMJ 1998; 316: 1858-63.

Garry PJ , Baumgartner RN , Brodie SG Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene. Clin Chem 1999; 45: 1214-23.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast Cancer and HRT: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 350: 1047-59.

Dupont WD , Page DL , Parl FF Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer 1999; 85: 1277-83.

Keeling D . Hormone replacement therapy and thrombosis. In: Hormone replacement therapy a guide for primary care. Eds Hope S , Rees M , and Brockie J . Oxford Medical Publications, 1999, pp 59-72

Lowe GD , Rumley A , Woodward M , Reid E , Rumley J . Activated protein C resistance and the FV: R506Q mutation in a random population sample - associations with cardiovascular risk factors and coagulation variables. Thromb Haemost 1999; 81: 918-24.

Hope S , Wager E , Rees MCP . Survey of British women's views on the menopause and HRT. J Br Meno Soc 1998; 4: 33-36.

Simon JA . Estrogen pharmacokinetics: Interindividual variations. In; Hormone replacement therapy: standardised or individually adapted doses? SS9-21. Parthenon publishing Group, London.

Simon JA , Robinson DE , Andrews MC The absorption of oral micronized progesterone: The effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil Steril 1993; 60: 26-33.

Ingelman-Sundberg M , Oscarson M , McLellan RA . Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment. Trends in Pharmacological Sciences 1999; 20: 342-49.

Linder MW , Valdes R Jr. , Fundamentals and applications of pharmacogenetics for the clinical laboratory. Ann Clin Lab Sci 1999; 29: 140-9.

Bailey LR , Roodi N , Dupont WD , Pari FF . Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Res 1998; 58: 5038-41.

Taioli E , Brad low HL , Garbers SV Role of estradiol metabolism and CYP1 Al polymorphisms in breast cancer risk. Cancer Detect Prev 1999; 23: 232-7.

Abplanalp W , Rymaszewski M , Adamski J , Subbiah MT Evidence for interference in estradiol-17 beta inactivation to estrone by oxidized low-density lipoprotein and selected lipid peroxidation products. J Lab Clin Med 1999; 134: 253-9.

Tanaka E . Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. J Clin Pharm Ther 1999; 24: 87-92.

Fattore C , Cipolla G , Gatti G , Limido GL , Sturm Y , Bernasconi C , Perucca E . Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women. Epilepsia 1999; 40: 783-7.